Vitamin D: Intestinal Absorption, Calcium Homeostasis, and Bone Health

Core Idea

Vitamin D functions as a hormone regulating calcium and phosphate homeostasis essential for bone mineralization and muscle function. In the intestine, active vitamin D (calcitriol) induces synthesis of calcium-binding proteins and increases transcellular calcium absorption. In bone, vitamin D promotes mineralization by maintaining optimal calcium and phosphate concentrations. Deficiency leads to impaired absorption and secondary hyperparathyroidism, resulting in bone demineralization.

How It's Best Learned

Trace vitamin D activation from skin synthesis through hepatic and renal hydroxylation to understand how sunlight exposure, kidney function, and parathyroid hormone regulate active vitamin D levels. Compare calcium absorption and bone dynamics in vitamin D sufficiency versus deficiency.

Explainer

Vitamin D sits at the intersection of sunlight, kidney function, and bone health in a way that reveals how tightly the body regulates its calcium supply. From your study of mineral homeostasis, you know that serum calcium must be maintained within a narrow range — too low causes tetanic muscle contractions, too high causes cardiac arrhythmias. Vitamin D is the body's primary long-term mechanism for ensuring enough calcium is absorbed from food in the first place. Without adequate vitamin D, no amount of dietary calcium can be effectively used.

The molecule itself is inert until activated by a two-step process. Skin produces cholecalciferol (vitamin D₃) when UV-B radiation converts a cholesterol precursor in epidermal cells. Cholecalciferol is also absorbed from fatty foods (fish, fortified dairy). In the liver, it is hydroxylated to 25-hydroxyvitamin D (calcidiol) — the storage form measured in blood tests. This form circulates but still has minimal biological activity. The critical second step occurs in the kidney: 1α-hydroxylase (CYP27B1) converts calcidiol to calcitriol (1,25-dihydroxyvitamin D), the active hormone. This final step is stimulated by parathyroid hormone (PTH) when serum calcium falls, and suppressed when calcium is adequate — making the kidney the master regulator of vitamin D activation.

In the intestine, calcitriol acts as a steroid hormone: it binds the vitamin D receptor (VDR) in enterocyte nuclei, which then upregulates genes encoding TRPV6 (a luminal calcium channel) and calbindin (an intracellular calcium-binding protein that shuttles calcium across the cell). This transcriptional mechanism explains both why vitamin D effects take hours to manifest (gene transcription takes time) and why gut calcium absorption can be efficiently scaled — more calcitriol means more channels and transporters, more calcium absorbed. Without calcitriol, only about 10–15% of dietary calcium is absorbed passively; with adequate calcitriol, this rises to 30–40%.

Bone health depends on vitamin D indirectly but powerfully. Calcitriol does not directly deposit calcium into bone — that is the job of osteoblasts acting on hydroxyapatite. But calcitriol ensures that the blood calcium-phosphate product remains high enough for spontaneous mineralization to occur. In vitamin D deficiency, intestinal calcium absorption falls, serum calcium begins to drop, and PTH rises in compensation (secondary hyperparathyroidism). PTH mobilizes calcium by stimulating osteoclast-mediated bone resorption. The bones are essentially stripped to maintain blood calcium. In children, this produces rickets (soft, deformable bones); in adults, osteomalacia (inadequately mineralized bone matrix that is soft and painful). Understanding this cascade — low vitamin D → poor absorption → low calcium → high PTH → bone loss — explains why treating vitamin D deficiency with calcium alone is insufficient and why renal failure patients develop severe bone disease despite normal dietary calcium intake.